Why This Seattle Biotech Could be an M&A Target Post author:Sam Post published:January 18, 2018 Post category:BioPharma Immune Design is a clinical-stage immunotherapy company. Source: BioSpace You Might Also Like Harpoon Medical's 16-Employee Office Will Stay Intact After Edwards Lifescience's $100M Acquisition December 12, 2017 This Tiny Biotech Grew 412% in 2016. A Look at Whether It Can Continue in 2017 February 20, 2017 Argos Surges on Positive Phase III Kidney Cancer Data November 12, 2017
Harpoon Medical's 16-Employee Office Will Stay Intact After Edwards Lifescience's $100M Acquisition December 12, 2017
